Neovasc Inc
TSX:NVCN
Operating Margin
Neovasc Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
|
Neovasc Inc
TSX:NVCN
|
110.5m CAD |
-872%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
227B USD |
18%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.1B USD |
29%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
152.1B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.6B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
119.1B USD |
20%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.7B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
56.2B USD |
14%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.4B USD |
31%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46B USD |
28%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
42B USD |
33%
|
Neovasc Inc
Glance View
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures and markets products for the cardiovascular marketplace. The firm's products include the Neovasc ReducerTM (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle and the TiaraTM (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Neovasc Inc's most recent financial statements, the company has Operating Margin of -871.8%.
You don't have any saved screeners yet